Prestige BioPharma Reports Positive Top-Line Phase III Results for Tuznue (Trastuzumab Biosimilar) Read more
Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies Read more
GENFIT and Terns Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China Read more
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma Read more
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer Read more
Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership Read more
Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases Read more